Login

Financial Snapshot

Revenue
TTM
$783.1K
Gross Margin
TTM
100.0%
Net Income
TTM
$117.6K
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
84.93%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$966.1K
Cash
2026 Q1
P/E
TTM
309.7
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $36.422 Million

About Family Office of America Inc

Family Office of America Inc (FOFA) is a development-stage medical device company that has not yet generated cash flow from operations as of the fiscal year ended December 31, 2025. The company's primary development focus is a device called SOLACE, which had not completed development as of the 10-K filed April 16, 2026. FOFA reported a net loss before income taxes of $492,748 for the year ended December 31, 2025, compared to a net loss of $100,484 for the year ended December 31, 2024. Total assets were $1,543,042 as of December 31, 2025, up from $20,581 as of December 31, 2024. The company acknowledged limited operating history, no cash flow from operations, and dependence on future financing to continue operations. In 2021, FOFA acquired mPathix Health, Inc. (formerly EMF Medical Devices, Inc.) through a share exchange. Acting CEO Patrick Adams and Director of Acquisitions Ulderico Conte each held warrants issued January 15, 2025, exercisable at $0.10 per share for five years.

Revenue model
The company had not generated revenue from operations as of the fiscal year ended December 31, 2025. Expenses for FY2025 included professional fees, consulting fees, compensation costs, and general and administrative costs. The company is pre-revenue and reliant on external financing.
Products and services
SOLACE device (medical device, development not finalized as of the 10-K filed April 16, 2026). The company previously acquired mPathix Health, Inc. (formerly EMF Medical Devices, Inc.) in June 2021.
Customers and end markets
No customers or end market revenue disclosed in the filing excerpts. The company had not generated cash flow from operations as of December 31, 2025.
Value-chain role
Pre-commercial medical device developer. The company is in the product development stage with no finalized device or commercial sales as of the filing date.
Geographic exposure
Incorporated in the United States; registered with the SEC. No geographic revenue breakdown disclosed in the filing excerpts.

Source: SEC 10-K, filed 2026-04-16

Industry: Surgical & Medical Instruments & Apparatus Peers: Smart Share Global Ltd

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support